Karen Ling's most recent trade in Bausch + Lomb Corp was a trade of 4,000 Common Shares, No Par Value done . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch + Lomb Corp | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 4,000 | 45,676 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Karen L. Ling | Director | Purchase of securities on an exchange or from another person at price $ 17.74 per share. | 19 Feb 2026 | 4,000 | 41,676 | - | 17.7 | 70,968 | Common Shares, No Par Value |
| iRhythm Tech Inc | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 1,358 | 9,568 (0%) | 0% | 0 | Common Stock | |
| Bausch + Lomb Corp | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 20,338 | 37,676 | - | 0 | Common Shares, No Par Value | |
| Bausch + Lomb Corp | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 14,696 | 17,338 | - | 0 | Common Shares, No Par Value | |
| iRhythm Tech Inc | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 1,841 | 8,210 (0%) | 0% | 0 | Common Stock | |
| Bausch + Lomb Corp | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 2,642 | 2,642 | - | 0 | Common Shares, No Par Value | |
| iRhythm Tech Inc | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 1,396 | 6,369 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Karen L. Ling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Karen L. Ling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 4,591 (0%) | 0% | - | Common Stock | |
| iRhythm Tech Inc | Karen L. Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 653 | 4,973 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Karen Ling | Director | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 17 Aug 2021 | 33,445 | 130,309 (0%) | 0% | 0.8 | 25,084 | Common Stock |
| TherapeuticsMD Inc | Karen Ling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Karen Ling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 96,864 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Karen Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 99,174 | 99,174 | - | - | Restricted Stock Units |